:format(jpg)/f.elconfidencial.com%2Foriginal%2F970%2F2c5%2Fff3%2F9702c5ff3fb135c1246b4f766694f614.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F970%2F2c5%2Fff3%2F9702c5ff3fb135c1246b4f766694f614.jpg)
Grifols califica de “prometedor” el primer resultado de su estudio sobre el alzhéimer
Marcos Lamelas. Barcelona
:format(jpg)/f.elconfidencial.com%2Foriginal%2F4e7%2F2e8%2F8d1%2F4e72e88d1b087d8f4753811566d0146a.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F4e7%2F2e8%2F8d1%2F4e72e88d1b087d8f4753811566d0146a.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fa44%2F44c%2F945%2Fa4444c945d5e584586cbe14e76ac332b.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fa44%2F44c%2F945%2Fa4444c945d5e584586cbe14e76ac332b.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fd75%2Febf%2F93b%2Fd75ebf93b9fdc36acd3b90c46f5f6df9.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fd75%2Febf%2F93b%2Fd75ebf93b9fdc36acd3b90c46f5f6df9.jpg)
Grifols redobla su apuesta americana: compra en Memphis por 184 millones
Marcos Lamelas. Barcelona
:format(jpg)/f.elconfidencial.com%2Foriginal%2F809%2Fe35%2F17e%2F809e3517efab9271c2129e167623f0ae.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F809%2Fe35%2F17e%2F809e3517efab9271c2129e167623f0ae.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ffea%2Fdb2%2Febb%2Ffeadb2ebb131d8e9008f7bac647cf260.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ffea%2Fdb2%2Febb%2Ffeadb2ebb131d8e9008f7bac647cf260.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F378%2Fb4f%2Fc3e%2F378b4fc3e9146cbfeb7d841e106366a1.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F378%2Fb4f%2Fc3e%2F378b4fc3e9146cbfeb7d841e106366a1.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fd4a%2F5d8%2F90b%2Fd4a5d890b8dc4111fd4f080b9fa5f637.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fd4a%2F5d8%2F90b%2Fd4a5d890b8dc4111fd4f080b9fa5f637.jpg)
Vela catalana a La Moreneta
Graciano Palomo
:format(jpg)/f.elconfidencial.com%2Foriginal%2F462%2Ff44%2F3ca%2F462f443ca8de1055d620fd44f0e2cfd2.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F462%2Ff44%2F3ca%2F462f443ca8de1055d620fd44f0e2cfd2.jpg)
Las farmacias catalanas, desabastecidas: "Mas nos utiliza como arma contra Rajoy"
Eva Pastrana. Barcelona
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fa4b%2F01e%2Fd48%2Fa4b01ed488980495782f136bb117bc41.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fa4b%2F01e%2Fd48%2Fa4b01ed488980495782f136bb117bc41.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F64b%2F2c9%2Fc6f%2F64b2c9c6f2336b7c430edf2afdd5ce48.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F64b%2F2c9%2Fc6f%2F64b2c9c6f2336b7c430edf2afdd5ce48.jpg)
Farmacias: mis principios o la ley
Daniel Jarreta
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fca9%2F99a%2Fad0%2Fca999aad00a46b11839ed0bd176d1eb9.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fca9%2F99a%2Fad0%2Fca999aad00a46b11839ed0bd176d1eb9.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fde4%2F0cc%2F5a7%2Fde40cc5a7d63c4a4ebe3c6fe66839a76.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fde4%2F0cc%2F5a7%2Fde40cc5a7d63c4a4ebe3c6fe66839a76.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F2d8%2F9ab%2F5a0%2F2d89ab5a0193bb017feb92e5d27a712e.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F2d8%2F9ab%2F5a0%2F2d89ab5a0193bb017feb92e5d27a712e.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F486%2Feea%2Fe5e%2F486eeae5ebd0cd9f7e8ee9af58d12040.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F486%2Feea%2Fe5e%2F486eeae5ebd0cd9f7e8ee9af58d12040.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F040%2Fc70%2Fe71%2F040c70e71b4be78724979bcf5442b5fb.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F040%2Fc70%2Fe71%2F040c70e71b4be78724979bcf5442b5fb.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F291%2Fd9c%2Fd3e%2F291d9cd3ef4889695ec0a2f2df231f4d.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F291%2Fd9c%2Fd3e%2F291d9cd3ef4889695ec0a2f2df231f4d.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F9dc%2F1da%2Fc98%2F9dc1dac98faeb5a1b5d5f91f068dab4e.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F9dc%2F1da%2Fc98%2F9dc1dac98faeb5a1b5d5f91f068dab4e.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F089%2F0e2%2F1e1%2F0890e21e1e4ea1b90d9d119a23ecb7ff.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F089%2F0e2%2F1e1%2F0890e21e1e4ea1b90d9d119a23ecb7ff.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F9c8%2F40b%2F859%2F9c840b8590ab45e87ae5a2dc0786f26f.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F9c8%2F40b%2F859%2F9c840b8590ab45e87ae5a2dc0786f26f.jpg)
Biotecnología con sesgo EEUU, de Credit Suisse
Paula Mercado
:format(jpg)/f.elconfidencial.com%2Foriginal%2F3e6%2F372%2Fb07%2F3e6372b0780b920d31eacbc09beda2bf.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F3e6%2F372%2Fb07%2F3e6372b0780b920d31eacbc09beda2bf.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F65a%2F0da%2F784%2F65a0da784f270bb482ff3039e086a5e1.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F65a%2F0da%2F784%2F65a0da784f270bb482ff3039e086a5e1.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F703%2F96f%2Fae8%2F70396fae83a43057abee31de48e2c9d7.jpg)
:format(jpg)/f.elconfidencial.com%2Foriginal%2F703%2F96f%2Fae8%2F70396fae83a43057abee31de48e2c9d7.jpg)